BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 21435744)

  • 1. [Aspirin in the prevention of colorectal cancer].
    Zubiaurre L; Bujanda Fernández de Pierola L
    Gastroenterol Hepatol; 2011 May; 34(5):337-45. PubMed ID: 21435744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.
    Sandler RS
    Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal cancer prevention: is an ounce of prevention worth a pound of cure?
    Gill S; Sinicrope FA
    Semin Oncol; 2005 Feb; 32(1):24-34. PubMed ID: 15726503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase-2 expression and recurrence of colorectal adenomas: effect of aspirin chemoprevention.
    Benamouzig R; Uzzan B; Martin A; Deyra J; Little J; Girard B; Chaussade S;
    Gut; 2010 May; 59(5):622-9. PubMed ID: 20427397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention of colorectal cancer: acetylsalicyclic acid and cyclo-oxygenase-2 inhibitors are only partially effective].
    Kleibeuker JH; de Vries EG
    Ned Tijdschr Geneeskd; 2003 Nov; 147(45):2203-7. PubMed ID: 14640056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An introduction to aspirin, NSAids, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part II.
    Moyad MA
    Semin Urol Oncol; 2001 Nov; 19(4):306-16. PubMed ID: 11769882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.
    Sandler RS; Halabi S; Baron JA; Budinger S; Paskett E; Keresztes R; Petrelli N; Pipas JM; Karp DD; Loprinzi CL; Steinbach G; Schilsky R
    N Engl J Med; 2003 Mar; 348(10):883-90. PubMed ID: 12621132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use and safety of aspirin in the chemoprevention of colorectal cancer.
    Singh AK; Trotman BW
    J Assoc Acad Minor Phys; 1998; 9(2):40-4. PubMed ID: 9648425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of NSAIDs for the chemoprevention of colorectal cancer.
    Herendeen JM; Lindley C
    Ann Pharmacother; 2003 Nov; 37(11):1664-74. PubMed ID: 14565811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low dose aspirin, COX-inhibition and chemoprevention of colorectal cancer.
    Benamouzig R; Uzzan B; Little J; Chaussade S
    Curr Top Med Chem; 2005; 5(5):493-503. PubMed ID: 15974944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cyclooxygenase(COX)-2-inhibition in the prevention and treatment of colorectal carcinoma].
    Tuynman JB; Hulscher JB; Steller EP; van Lanschot JJ; Richel DJ
    Ned Tijdschr Geneeskd; 2003 Nov; 147(45):2207-12. PubMed ID: 14640057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevention of colorectal cancer by aspirin use.
    Giovannucci E
    Biomed Pharmacother; 1999 Aug; 53(7):303-8. PubMed ID: 10472428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial of aspirin to prevent colorectal adenomas.
    Baron JA; Cole BF; Sandler RS; Haile RW; Ahnen D; Bresalier R; McKeown-Eyssen G; Summers RW; Rothstein R; Burke CA; Snover DC; Church TR; Allen JI; Beach M; Beck GJ; Bond JH; Byers T; Greenberg ER; Mandel JS; Marcon N; Mott LA; Pearson L; Saibil F; van Stolk RU
    N Engl J Med; 2003 Mar; 348(10):891-9. PubMed ID: 12621133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of cytokine gene polymorphisms in colorectal cancer and their interaction with aspirin use in the northeast of Scotland.
    Macarthur M; Sharp L; Hold GL; Little J; El-Omar EM
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1613-8. PubMed ID: 16030091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin and the risk of colorectal cancer in women.
    Giovannucci E; Egan KM; Hunter DJ; Stampfer MJ; Colditz GA; Willett WC; Speizer FE
    N Engl J Med; 1995 Sep; 333(10):609-14. PubMed ID: 7637720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemopreventive agents in colorectal cancer].
    Benamouzig R; Chaussade S
    Rev Prat; 2003 Dec; 53(20):2213-4. PubMed ID: 15018072
    [No Abstract]   [Full Text] [Related]  

  • 17. Aspirin may be more effective in preventing colorectal adenomas in patients with higher BMI (United States).
    Kim S; Baron JA; Mott LA; Burke CA; Church TR; McKeown-Eyssen GE; Cole BF; Haile RW; Sandler RS
    Cancer Causes Control; 2006 Dec; 17(10):1299-304. PubMed ID: 17111262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies.
    Flossmann E; Rothwell PM;
    Lancet; 2007 May; 369(9573):1603-13. PubMed ID: 17499602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Celecoxib for the prevention of colorectal adenomatous polyps.
    Arber N; Eagle CJ; Spicak J; Rácz I; Dite P; Hajer J; Zavoral M; Lechuga MJ; Gerletti P; Tang J; Rosenstein RB; Macdonald K; Bhadra P; Fowler R; Wittes J; Zauber AG; Solomon SD; Levin B;
    N Engl J Med; 2006 Aug; 355(9):885-95. PubMed ID: 16943401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas.
    Baron JA; Sandler RS; Bresalier RS; Quan H; Riddell R; Lanas A; Bolognese JA; Oxenius B; Horgan K; Loftus S; Morton DG;
    Gastroenterology; 2006 Dec; 131(6):1674-82. PubMed ID: 17087947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.